• CD38 CAR Binder Structures and Affinity Tuning

  2026-10-04

  Cheng et al. combine structural, biochemical, and cellular analyses to show that the CD38 CAR binders RP02 and 028 recognize distinct antigen surfaces and produce different effects on CD38 enzymatic activity. Their data support affinity attenuation of 028 as a way to reduce CAR-T fratricide while preserving reported tumor-cell cytotoxicity, although the evidence remains preclinical and primarily in vitro.

• Cy3 TSA Fluorescence System Kit for Liver Cancer

  2026-10-02

  Discover how the Cy3 TSA Fluorescence System Kit can translate mechanistic findings on SIX1-driven lipid synthesis into spatially resolved assays. This guide combines TSA chemistry, liver cancer biology, controls, and practical assay-design decisions for detecting low-abundance biomolecules.

• ALC-0159: Reliable LNP Viability Assays

  2026-10-01

  This scenario-based guide shows how ALC-0159 (SKU B8596) can be incorporated into controlled mRNA lipid nanoparticle workflows without confusing a formulation excipient with an assay reporter. It connects assay controls, formulation comparisons, and evidence limits to practical selection of an ALC-0159 PEG lipid.

• Tomivosertib and the Translational Logic of eIF4E

  2026-10-01

  Tomivosertib offers translational researchers a precise way to interrogate MNK1/2-dependent eIF4E phosphorylation across oncology, metabolic, neuronal, and inflammatory models. This article connects the AMPK-MNK-eIF4E metabolic pathway to selective translation, tumor biology, and practical study design.

• SN-38 Disrupts FUBP1–FUSE Binding in Cancer Cells

  2026-09-30

  The reference study identified camptothecin and SN-38 as inhibitors of the FUBP1–FUSE DNA interaction, revealing a regulatory mechanism beyond their established topoisomerase I activity. Its findings support testing FUBP1-dependent transcription alongside DNA damage, apoptosis, and cell-cycle endpoints in carefully matched cancer models.

• Cy5 Goat Anti-Mouse IgG (H+L) for Vaccine Assays

  2026-09-30

  Explore how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can connect ferritin-based vaccine research with rigorous fluorescent endpoint design. This article translates particle-immunology findings into practical choices for mouse IgG detection, multiplexing, and assay validation.

• ABT-888 (Veliparib) DNA Repair Workflow

  2026-09-29

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for building DNA damage-response, chemotherapy-sensitization, and radiation-response assays. This guide connects practical dosing and assay controls with colorectal cancer models and the biomarker-led CHK1 research landscape.

• IL-2 Human Recombinant: Mechanism and Workflow

  2026-09-29

  IL-2, human recombinant is a research cytokine for studying interleukin-2 receptor signaling in receptor-competent cells. The cited FUS–SMN study establishes a separate neuronal phase-separation mechanism and does not demonstrate that IL-2 modulates neuronal granules.

• γH2AX DNA Damage Detection Kit for DSB Research

  2026-09-28

  Translate radiation, nanoparticle, and genotoxicity experiments into measurable nuclear γ-H2AX signals with a red-fluorescence workflow suited to microscopy and high-content screening. This guide combines practical assay setup, treatment-specific controls, and troubleshooting for reproducible DNA double-strand break detection.

• Carvacrol in TRPA1 Redox-Sensing Workflows

  2026-09-28

  Use Carvacrol as a non-electrophilic TRPA1 agonist to test channel function after oxidative challenge—not as a substitute for a reactive oxygen species. This workflow separates acute ion-channel readouts from Carvacrol’s distinct cell-cycle and apoptosis research applications, with practical controls for each.

• Topotecan HCl Workflows for Cancer Assays

  2026-09-27

  Use Topotecan HCl to study replication-linked DNA damage while separating growth arrest from actual cell killing. Model-specific concentration and exposure windows, paired with distinct response readouts, make its cancer-assay results more interpretable.

• Amikacin Sulfate Workflows for NTM Research

  2026-09-26

  Pair extracellular CFU measurements with intracellular dendritic-cell assays to distinguish Amikacin activity from delivery and cell-response effects. This workflow also shows how kidney-safety context can inform interpretation without implying an unproven interaction between nicotine exposure and amikacin.

• Cy3 TSA Fluorescence System Kit: Cancer Research

  2026-09-25

  The Cy3 TSA Fluorescence System Kit uses HRP-catalyzed tyramide deposition to amplify fluorescence microscopy detection in IHC, ICC, and ISH. It can support detection of low-abundance biomolecules, but it does not replace target-specific probes, antibodies, or assay validation.

• TCF25 Links Glucose Sensing to Lysosomal Cell Death

  2026-09-25

  A genome-wide CRISPR-Cas9 screen identifies TCF25 as a regulator that helps cells adapt to glucose deprivation by enhancing V-ATPase-dependent lysosomal acidification. With prolonged starvation, the same pathway promotes ferritinophagy and lysosome-dependent cell death, while TCF25 deficiency protects mice in a hepatic ischemia-reperfusion model.

• E-4031 for 3D Cardiac Electrophysiology Research

  2026-09-24

  Pair E-4031-mediated hERG blockade with shell microelectrode arrays to test how delayed repolarization changes electrical wave propagation across cardiac organoids—not just activity at a planar contact surface. This workflow combines a controlled dose-response, spatial mapping, and calcium-imaging validation while flagging key limits in interpreting proarrhythmic phenotypes.

8528 records 1/569 page Next 12345 下5页 Last page